Kala Bio KALA
NASDAQ KALA
$0.16 +0.01 (+4.37%)
As of: Nov 9, 2026 · 9:58 AM EST

Kala Bio (KALA) Net Preferred Shares Issued and Repurchased (2024 - 2026)

Updated

Kala Bio's Net Preferred Shares Issued and Repurchased was $4.1 million in Q1 2026.

Analysis

Kala Bio (KALA) Net Preferred Shares Issued and Repurchased (2024 - 2026) Analysis & Trends

For FY2025, Net Preferred Shares Issued and Repurchased at Kala Bio came in at $1.8 million, down 78.9% from FY2024.

  • In earlier years, Net Preferred Shares Issued and Repurchased was $8.54 million in FY2024 (+334.5%) and $1.97 million in FY2023.
  • The Q1 2026 figure marks the highest quarterly Net Preferred Shares Issued and Repurchased since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,242.36 Bn 1,215.98 Bn 20.46 Bn -
2 Johnson & Johnson 668.81 Bn 588.67 Bn 17.30 Bn -
3 AbbVie 515.10 Bn 483.11 Bn 13.12 Bn -
4 Merck 362.39 Bn 325.33 Bn 13.19 Bn -
5 Novartis Ag 314.14 Bn 287.38 Bn - -
6 Astrazeneca 291.23 Bn 265.12 Bn 13.26 Bn -
7 Amgen 248.23 Bn 199.89 Bn 7.58 Bn -
8 Gilead Sciences 208.43 Bn 183.54 Bn 6.73 Bn -
9 Pfizer 165.78 Bn 113.13 Bn 12.56 Bn -
10 Kala Bio 2.48 Mn -42.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.10 Mn
Mar 31, 2024 8.54 Mn
API Access

Kala Bio Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=KALA&period=max&api_key=YOUR_API_KEY